Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
FORT MYERS, Fla., Aug. 26, 2016 -- 21st Century Oncology Holdings, Inc. ("21C Holdings" or the "Company"), the largest global, physician led provider of integrated cancer care (“ICC”) services, today announced that it will host a conference call on Wednesday, August 31, 2016 at 11:00 a.m. Eastern Time, during which management will discuss the financial results of the fourth quarter and year ended December 31, 2015 and its restated financial statements for prior periods. The conference call and replay of the conference call may be accessed as follows:
Dial-in numbers: 877-407-9039 (Domestic); 201-689-8470 (International)
Replay Dial-in Numbers (Available until September 14, 2016): 877-870-5176 (Domestic); 858-384-5517 (International); Replay Pin Number: 13644461
A live webcast and webcast replay of the call will also be available from the Events section of the corporate web site at www.21co.com.
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.
21st Century Oncology Contact: LeAnne M. Stewart Chief Financial Officer 239-931-7281 [email protected] Investor Contact: The Ruth Group Nick Laudico 646-536-7030 [email protected] Brandon Vazquez 646-536-7032 [email protected]
